Responses
Clinical and epidemiological research
Extended report
Efficacy and safety of secukinumab in patients with rheumatoid arthritis: a phase II, dose-finding, double-blind, randomised, placebo controlled study
Compose a Response to This Article
Other responses
No responses have been published for this article.